Vor Biopharma Inc.

1. 01

   9.0 days to cover short interest

   7.4M shares were sold short at the 15 Oct 2026 settlement, 12.1% of the 61.4M shares outstanding; covering them would take 9.0 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

2. 02

   Behind SPY and its sector fund XLV over 1 year

   1 month: +9.9% (SPY −1.6%, XLV +13.5%). 3 months: −9.7% (SPY −0.4%, XLV +15.5%). 1 year: −2.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: VOR, SPY and XLV · as of 4 Nov 2026

3. 03

   Below its 50-day average, above its 200-day

   The 4 Nov 2026 close of $20.12 was 2.0% below its 50-day average ($20.53) and 15.7% above its 200-day average ($17.39). It has closed above the 200-day for 91 sessions, since 29 Jun 2026. The 50-day average crossed above the 200-day on 22 Jul 2026, 74 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   Light volume: 0.4× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 415.4K shares was 0.4× the average of the 30 sessions before it (939.6K), as the price rose 1.3%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

5. 05

   70% of the way up its 52-week range

   Closed at $20.12 on 4 Nov 2026: 22.6% below the 52-week high of $26.00 (8 Sep 2026) and 209.5% above the low of $6.50 (20 Nov 2025).

   Daily price bars, split-adjusted · as of 4 Nov 2026

At the 4 Nov 2026 close